Publication: Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy
Issued Date
2018-10-01
Resource Type
ISSN
14732165
14732130
14732130
Other identifier(s)
2-s2.0-85050376404
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Cosmetic Dermatology. Vol.17, No.5 (2018), 712-718
Suggested Citation
Wilai Thanasarnaksorn, Sebastian Cotofana, Christina Rudolph, Patcharahatai Kraisak, Nongsak Chanasumon, Atchima Suwanchinda Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy. Journal of Cosmetic Dermatology. Vol.17, No.5 (2018), 712-718. doi:10.1111/jocd.12705 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/46298
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Severe vision loss caused by cosmetic filler augmentation: Case series with review of cause and therapy
Abstract
© 2018 Wiley Periodicals, Inc. Hyaluronic acid (HA) injection is a popular nonsurgical, facial rejuvenating procedure. Due to the rapidly expanding use of HA injections, significant potential complications have also increased in frequency. Among these complications, the rare but most devastating one is arterial occlusion, which can result in skin necrosis or blindness. To describe the mechanisms behind vision loss secondary to hyaluronic acid injection and the efficacy of treatments to restore vision and associated ocular functionality. We reviewed six cases of patients from October 2011 to December 2017 who experienced vision loss after receiving facial HA injections and the subsequent treatments undertaken to attempt to reverse the vision loss and additional eye complications. Of the six patients, four received nose, one received forehead, and another one received temple injections. All six patients developed vision loss secondary to hyaluronic acid embolization in retinal or ophthalmic arteries. Additional complications included severe periorbital pain, ptosis, impairment of extraocular muscle functionality. Recovery of vision was dependent on the type, frequency, and duration of subsequent treatment. Vision loss is a rare but catastrophic complication caused by hyaluronic injection that occurs secondary to hyaluronic acid embolization in retinal or ophthalmic arteries due to retrograde flow from facial vascular anastomoses. We suggest the early supratrochlear/supraorbital hyaluronidase injection, ocular massage, and re-breathing into a plastic bag as safe, uncomplicated and effective methods to restore the retinal circulation and reverse vision loss.